10-51697926-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015235.3(CSTF2T):c.1624G>A(p.Gly542Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000482 in 1,599,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015235.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000660 AC: 10AN: 151496Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000537 AC: 12AN: 223544Hom.: 0 AF XY: 0.0000498 AC XY: 6AN XY: 120478
GnomAD4 exome AF: 0.0000463 AC: 67AN: 1447538Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 29AN XY: 719018
GnomAD4 genome AF: 0.0000660 AC: 10AN: 151614Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74102
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.1624G>A (p.G542S) alteration is located in exon 1 (coding exon 1) of the CSTF2T gene. This alteration results from a G to A substitution at nucleotide position 1624, causing the glycine (G) at amino acid position 542 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at